| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 529.07M | 547.31M | 579.37M | 609.62M | 556.87M | 458.70M |
| Gross Profit | 110.87M | 120.32M | 179.16M | 241.35M | 213.24M | 172.59M |
| EBITDA | -84.96M | -81.59M | 45.08M | 66.36M | 53.41M | 38.87M |
| Net Income | -125.48M | -126.34M | 7.52M | 27.40M | 18.59M | 15.24M |
Balance Sheet | ||||||
| Total Assets | 651.98M | 636.72M | 767.55M | 726.31M | 694.16M | 667.18M |
| Cash, Cash Equivalents and Short-Term Investments | 14.48M | 12.51M | 11.42M | 20.33M | 16.29M | 15.92M |
| Total Debt | 208.53M | 167.81M | 162.09M | 76.25M | 78.08M | 119.81M |
| Total Liabilities | 421.16M | 403.61M | 397.54M | 356.33M | 321.42M | 306.45M |
| Stockholders Equity | 230.82M | 233.11M | 370.01M | 369.98M | 372.74M | 360.74M |
Cash Flow | ||||||
| Free Cash Flow | 18.30M | -3.77M | -70.81M | 42.55M | 77.28M | 77.95M |
| Operating Cash Flow | 20.54M | 3.92M | -58.75M | 57.10M | 87.32M | 89.20M |
| Investing Cash Flow | -1.28M | -6.62M | -17.02M | -14.47M | -20.04M | -35.80M |
| Financing Cash Flow | -24.27M | 4.54M | 66.74M | -38.26M | -65.87M | -43.21M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | $1.05B | 8.28 | 42.00% | 11.96% | 16.52% | 141.96% | |
62 Neutral | $111.00M | -2.16 | ― | ― | -28.28% | -1718.93% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
53 Neutral | $338.49M | ― | -33.37% | ― | 8.88% | -349.99% | |
46 Neutral | $139.70M | ― | -973.22% | ― | 57.83% | 40.94% | |
44 Neutral | $155.59M | ― | ― | ― | ― | ― | |
40 Underperform | $145.00M | ― | -42.97% | ― | -9.57% | -3226.39% |
On August 18, 2025, American Vanguard‘s subsidiary, AMVAC Chemical Corporation, amended its senior credit facility with a group of commercial lenders led by BMO Bank. The amendment extends the maturity date of the loan agreement to December 31, 2026, and adjusts the borrowing capacity under the revolving credit facility. This extension is seen as a vote of confidence in American Vanguard’s ongoing transformation and improvement, allowing the management to better demonstrate the company’s earnings potential to investors.
The most recent analyst rating on (AVD) stock is a Buy with a $12.00 price target. To see the full list of analyst forecasts on American Vanguard stock, see the AVD Stock Forecast page.
On July 31, 2025, American Vanguard reported its financial results for the second quarter ended June 30, 2025. The company achieved a substantial improvement in adjusted EBITDA, which increased by more than 80% compared to the previous year, reaching $11 million. The gross profit margin improved to 31% from 29% last year, driven by enhancements in manufacturing and procurement processes. The company also reduced its debt by $22 million and inventory by $53 million compared to the previous year. CEO Dak Kaye highlighted the company’s progress in business transformation and operational improvements, which have been supported by an early recovery in the agriculture economy. American Vanguard reiterated its full-year 2025 revenue and adjusted EBITDA targets, emphasizing continued efforts to control expenses and maximize investor returns.
The most recent analyst rating on (AVD) stock is a Buy with a $12.00 price target. To see the full list of analyst forecasts on American Vanguard stock, see the AVD Stock Forecast page.
American Vanguard Corporation is a company that develops, manufactures, and distributes chemical, biological, and biorational products primarily for agricultural, commercial, and consumer use. In its latest earnings report for the quarter ending June 30, 2025, American Vanguard Corporation reported net sales of $129.3 million, a slight increase from the previous year. However, the company faced a net loss of $849,000, an improvement from the $11.7 million loss in the same quarter of the previous year. Key financial metrics showed a gross profit of $40.5 million, with operating income reaching $4.4 million, a significant turnaround from the $9.2 million operating loss in the prior year. Despite the challenges, the company managed to reduce operating expenses and transformation costs significantly. Looking ahead, American Vanguard Corporation remains focused on its digital and structural transformation projects to enhance operational efficiency and improve financial performance.